Vaccine News and Research

Latest Vaccine News and Research

FDA approves Protein Sciences’ Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

18 Jan 2013

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels.

18 Jan 2013

WHO finds decline in number of measles deaths between 2000 and 2011

The number of measles deaths globally decreased by 71% between 2000 and 2011, from 542 000 to 158 000. Over the same period, new cases dropped 58% from 853 500 in 2000 to 355 000 in 2011, according to new data released Thursday by WHO, a leading member of the Measles and Rubella Initiative.

18 Jan 2013

Efforts to correct false beliefs about health care reform may backfire

Efforts to correct false beliefs about health care reform may backfire, depending on individuals' political views and level of knowledge, suggests a study in the February issue of Medical Care.

18 Jan 2013

Viewpoints: Obama 'wise' to add mental health focus to gun initiative; Calif. considers giving localities responsibility for expanded Medicaid

President Obama's sweeping proposals to combat gun violence represent a sound response to the mass shootings that have horrified the country. In his legislative proposals and executive actions announced Wednesday, the president and Vice President Biden showed a willingness to confront a difficult problem head-on -- a problem that is not only about laws but also about culture and mental-health care.

17 Jan 2013

MPL vaccine can stimulate brain's natural defense mechanisms in people with AD

A team of researchers from Universit- Laval, CHU de Qu-bec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease.

17 Jan 2013

New menu of 61 genetically engineered E. coli strains may improve efficacy of vaccines

Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.

17 Jan 2013

H1N1 flu vaccination during pregnancy does not increase risk of fetal loss

Norwegian pregnant women who received a vaccine against the 2009 H1N1 influenza virus showed no increased risk of pregnancy loss, while pregnant women who experienced influenza during pregnancy had an increased risk of miscarriages and still births, a study has found. The study suggests that influenza infection may increase the risk of fetal loss.

17 Jan 2013

WHO warns of dengue's spread, says progress made against NTDs in new report

"Dengue is the world's fastest-spreading tropical disease and represents a 'pandemic threat,' infecting an estimated 50 million people across all continents, the World Health Organization (WHO) said on Wednesday," Reuters reports.

17 Jan 2013

Protein Sciences receives FDA approval for Flublok vaccine

The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the prevention of seasonal influenza in people 18 through 49 years of age.

16 Jan 2013

India marks two years since last diagnosed polio case

On January 13, India "completed two years since the last case of the crippling disease was reported ... a huge achievement for a country that as recently as 2009 reported 741 cases of polio -- more than any other country in the world, and almost half of cases reported globally that year," the Wall Street Journal's "India Real Time" blog reports.

16 Jan 2013

WHO recommends switching to injectable polio vaccine

"[T]his month the World Health Organization (WHO) in Geneva, Switzerland, proposed a shift in [polio] vaccination strategy from oral vaccines to injected ones that may have to be administered in clinics," Nature reports, adding, "The change is needed to mop up the last remaining pockets of polio, but experts say that it poses challenges in [rural areas], which have poor access to health care."

16 Jan 2013

Addressing cholera with an 'integrated approach' in 2013

"There has been so much news related to cholera and cholera research since the start of 2013 I can only hope it means this year will be a banner year for prevention efforts," Helen Matzger, a program officer in new vaccine delivery at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog.

16 Jan 2013

Gates Foundation official discusses efforts to fight malaria

AllAfrica features an interview with David Brandling-Bennett, deputy director of the malaria program at the Bill & Melinda Gates Foundation, in which he discusses "current tools being used to fight the disease, the prospect for a vaccine, and the hope of new drugs to accelerate progress," according to the news service.

16 Jan 2013

Flu: ERs seeing more patients, N.Y. declares state of emergency

Emergency rooms around America are dealing with an influx of those with the flu while the virus forces New York officials to declare a state of emergency.

16 Jan 2013

Malaria control: an interview with Dr Jo Lines

Malaria is a tropical, mosquito-borne disease. It is found all over the tropics, in every continent but diminished now a great deal in most of Latin America, most of Asia. Still 90% of the world’s deaths due to malaria – are in Africa and most of them are in young children in Africa.

16 Jan 2013